ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

Mylan Confirms Endo Suit Over Generic Migraine Drug Application

DOW JONES NEWSWIRES Mylan Inc. (MYL) confirmed Wednesday that it has been sued by Endo Pharmaceuticals Holdings Inc. (ENDP) over its application for approval of a generic drug used to treat acute migraine headaches in adults. Mylan--one of the world's largest generic drug makers--said it believes it is the first company to file a substantially complete application for approval of frovatriptan succinate EQ, a generic version of Frova. The company said it expects to qualify for 180 days of marketing exclusivity upon final approval from the Food and Drug Administration. Mylan, which has had litigation-related charges figure prominently in its recent quarterly results, last month reported second-quarter earnings surged 70% as sales got a lift from a weaker dollar. Shares closed Tuesday at $20.01 and were inactive in recent premarket trade. Through the latest close, the stock is down 5.3% since the start of the year. -By Mia Lamar, Dow Jones Newswires; 212-416-3207;

Stock News for Mylan Inc. (MYL)
05/23/201512:03:02Billionaire George Soros Just Sold These 3 Stocks: Should You?
05/23/201509:09:02Will Competition Cause Teva Pharmaceutical Industries ltd. To...
05/21/201517:00:06Law Firm Advising Teva Dismisses Mylan Objections
05/21/201516:55:12Law Firm Advising Teva on Bid Dismisses Mylan's Objections to...
05/20/201512:15:10What Is the S&P 500 Index?
05/12/201516:59:19Perrigo to Buy Patheon's Mexican Business
05/12/201516:56:41Perrigo to Buy Patheon's Mexican Business for $34 Million
05/12/201516:00:00Mylan to Present at the UBS Global Healthcare Conference
05/12/201507:30:00Mylan to Present at the Bank of America Merrill Lynch Health...
05/08/201506:21:19Quarterly Report (10-q)
05/07/201517:25:22Current Report Filing (8-k)
05/07/201511:37:02Why Mylan NVs Mega-Merger Triangle Sent Its Shares Up 22% in...
05/07/201506:30:00Fashion Icon, Chef and Actor Join Together to Share Personal...
05/06/201506:03:54Proxy Statement - Merger or Acquistion (preliminary) (prem14a)
05/05/201517:32:52Securities Registration: Business Combination (s-4)
05/05/201517:22:45Filing of Certain Prospectuses and Communications in Connection...
05/05/201517:20:35Filing of Certain Prospectuses and Communications in Connection...
05/05/201517:20:31Mylan's Revenue Misses on Currency Effects
05/05/201516:05:00Mylan First Quarter 2015 Constant Currency Revenue Increases...
05/05/201513:45:00Mylan Launches Generic Seasonale® Tablets

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations